Breaking News Instant updates and real-time market news.

TBPH

Theravance Biopharma

$37.44

-1.14 (-2.95%)

06:23
10/12/16
10/12
06:23
10/12/16
06:23

Theravance Biopharma downgraded to Underperform from Neutral at Baird

Baird analyst Brian Skorney downgraded Theravance Biopharma to Underperform citing "unsustainable" valuation and raised its price target to $24 from $19.

TBPH Theravance Biopharma
$37.44

-1.14 (-2.95%)

05/12/16
05/12/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amarin (AMRN) assumed with a Buy at Jefferies by analyst Hugo Ong, who said off-label Vascepa promotion in mixed dyslipidemia may be beginning to bear fruit. 2. Theravance Biopharma (TBPH) initiated with an Outperform at Leerink with analyst Paul Matteis saying he sees a favorable risk/reward ahead of a string of clinical/commercial catalysts over the next year. 3. Graphic Packaging (GPK) initiated with a Conviction Buy at Goldman. 4. Owens-Illinois (OI) initiated with a Sell at Goldman. 5. Sonoco Products (SON) initiated with a Neutral at Goldman. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/02/16
LEER
06/02/16
NO CHANGE
LEER
Outperform
GSK accelerated timeline for closed triple positive for Theravance, says Leerink
Leerink analyst Paul Matteis noted GlaxoSmithKline (GSK) announcement that, following discussions with the FDA, it plans to file an NDA for the once-daily closed triple Chronic Obstructive Pulmonary Disease therapy by the end of this year, which is sooner than the filing in early 2018 that was originally expected. The news is positive for Theravance Biopharma (TBPH), which stands to receive a 5%-9% net royalty on closed triple sales, Matteis tells investors. The firm reiterates its Outperform rating on Theravance shares, which are up 2.6% this morning.
06/20/16
GUGG
06/20/16
INITIATION
Target $30
GUGG
Buy
Theravance Biopharma initiated with a Buy at Guggenheim
Guggenheim analyst Louise Chen initiated Theravance Biopharma with a Buy and $30 price target.
08/03/16
BOFA
08/03/16
DOWNGRADE
Target $23
BOFA
Underperform
Theravance Biopharma downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad downgraded Theravance Biopharma to Underperform with a $23 price target saying shares are fully valued. The analyst sees limited upside catalysts near-term including phase 3 data on Revefenacin and phase 2a data on TD-6450 in hepatitis C, and said Vibativ sales growth remains slow.

TODAY'S FREE FLY STORIES

ARNC

Arconic

$25.54

0.24 (0.95%)

08:12
06/26/17
06/26
08:12
06/26/17
08:12
Periodicals
Arconic supplied flammable panels for use in Grenfell Tower, Reuters reports »

Six emails dating from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCUL

Ocular Therapeutix

$10.15

-1.39 (-12.05%)

08:12
06/26/17
06/26
08:12
06/26/17
08:12
Hot Stocks
Ocular Therapeutix reports inducement grant under NASDAQ Listing Rule 5635(c)(4) »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

XLF

Financial Select Sector

$23.89

-0.09 (-0.38%)

, XLV

Health Care Select Sector SPDR

$80.47

-0.12 (-0.15%)

08:11
06/26/17
06/26
08:11
06/26/17
08:11
Technical Analysis
Technical View: SPDR S&P 500 ETF Trust breaks pivot high »

The SPDR S&P 500 ETF…

XLF

Financial Select Sector

$23.89

-0.09 (-0.38%)

XLV

Health Care Select Sector SPDR

$80.47

-0.12 (-0.15%)

SPY

SPDR S&P 500 ETF Trust

$243.13

0.29 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$6.06

0.24 (4.12%)

08:09
06/26/17
06/26
08:09
06/26/17
08:09
Hot Stocks
ImmunoGen presents data from Phase 1 study of IMGN779 in AML »

ImmunoGen presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

CBIO

Catalyst Biosciences

$4.53

0.02 (0.44%)

08:09
06/26/17
06/26
08:09
06/26/17
08:09
Hot Stocks
Catalyst says new data support ongoing trial of CB 2679d in hemophilia B »

Catalyst Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NLSN

Nielsen

$37.46

0.32 (0.86%)

, FRED

Fred's

$10.25

0.38 (3.85%)

08:08
06/26/17
06/26
08:08
06/26/17
08:08
Hot Stocks
Nielsen, Fred's expand strategic analytics relationship »

Nielsen (NLSN) and…

NLSN

Nielsen

$37.46

0.32 (0.86%)

FRED

Fred's

$10.25

0.38 (3.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 27

    Jul

ATOS

Atossa Genetics

$0.53

0.0228 (4.50%)

08:07
06/26/17
06/26
08:07
06/26/17
08:07
Hot Stocks
Atossa says receives 'positive' interim safety assessment in Phase 1 study »

Atossa Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNF

FNF Group

$44.58

0.43 (0.97%)

08:07
06/26/17
06/26
08:07
06/26/17
08:07
Hot Stocks
FNF Group acquires majority stake in Title Guaranty of Hawaii »

Fidelity National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$95.91

1.05 (1.11%)

08:07
06/26/17
06/26
08:07
06/26/17
08:07
Upgrade
Visteon rating change  »

Visteon upgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$66.05

0.96 (1.47%)

08:07
06/26/17
06/26
08:07
06/26/17
08:07
Hot Stocks
Fortune Brands Home & Security appoints Patrick Hallinan CFO »

Fortune Brands Home &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UN

Unilever; also tag UL

$55.68

0.08 (0.14%)

, UL

Unilever; also tag UN

$54.35

0.03 (0.06%)

08:06
06/26/17
06/26
08:06
06/26/17
08:06
Periodicals
Unilever threatens to pull ads from Google, Facebook, Times of London says »

Unilever (UN, UL) has…

UN

Unilever; also tag UL

$55.68

0.08 (0.14%)

UL

Unilever; also tag UN

$54.35

0.03 (0.06%)

GOOG

Alphabet

$965.59

8.5 (0.89%)

GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

FB

Facebook

$155.07

1.67 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

VSAT

ViaSat

$66.73

0.73 (1.11%)

08:06
06/26/17
06/26
08:06
06/26/17
08:06
Hot Stocks
ViaSat awarded $88.3M in contracts from SPAWAR »

ViaSat has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBRV

Nabriva Therapeutics

$10.55

0.05 (0.48%)

, TRVN

Trevena

$2.52

0.03 (1.20%)

08:06
06/26/17
06/26
08:06
06/26/17
08:06
Hot Stocks
Nabriva names CEO Colin Broom, Trevena CCO Carrie Bourow to board »

Nabriva Therapeutics…

NBRV

Nabriva Therapeutics

$10.55

0.05 (0.48%)

TRVN

Trevena

$2.52

0.03 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

  • 26

    Sep

VOXX

VOXX

$7.85

0.25 (3.29%)

, TEL

TE Connectivity

$78.77

-0.04 (-0.05%)

08:05
06/26/17
06/26
08:05
06/26/17
08:05
Hot Stocks
VOXX to sell Hirschmann Car Communication to TE Connectivity »

VOXX International (VOXX)…

VOXX

VOXX

$7.85

0.25 (3.29%)

TEL

TE Connectivity

$78.77

-0.04 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOFT

Hooker Furniture

$39.40

-0.85 (-2.11%)

08:05
06/26/17
06/26
08:05
06/26/17
08:05
Conference/Events
Hooker Furniture management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

NEOT

Neothetics

$2.32

0.0501 (2.21%)

08:05
06/26/17
06/26
08:05
06/26/17
08:05
Hot Stocks
Neothetics: LIPO-202 did not demonstrate improvement in Phase 2 trial »

Neothetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTT

GTT Communications

08:05
06/26/17
06/26
08:05
06/26/17
08:05
Hot Stocks
GTT Communications to acquire Global Capacity »

GTT Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAFD

8point3 Energy

$14.62

0.22 (1.53%)

08:04
06/26/17
06/26
08:04
06/26/17
08:04
Hot Stocks
8point3 Energy increases quarterly distribution 3% to 26.42c per share »

8point3 Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

AMAG

AMAG Pharmaceuticals

$18.35

0.15 (0.82%)

, ATRS

Antares Pharma

$3.21

0.2 (6.64%)

08:04
06/26/17
06/26
08:04
06/26/17
08:04
Hot Stocks
AMAG Pharmaceuticals reports FDA filing acceptance for Makena sNDA »

AMAG Pharmaceuticals…

AMAG

AMAG Pharmaceuticals

$18.35

0.15 (0.82%)

ATRS

Antares Pharma

$3.21

0.2 (6.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 20

    Oct

VOXX

VOXX

$7.85

0.25 (3.29%)

, TEL

TE Connectivity

$78.77

-0.04 (-0.05%)

08:04
06/26/17
06/26
08:04
06/26/17
08:04
Hot Stocks
Breaking Hot Stocks news story on VOXX, TE Connectivity »

VOXX to sell Hirschmann…

VOXX

VOXX

$7.85

0.25 (3.29%)

TEL

TE Connectivity

$78.77

-0.04 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANY

Sphere 3D

$0.17

-0.0854 (-33.31%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Conference/Events
Sphere 3D to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

FRTA

Forterra

$7.73

0.18 (2.38%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Hot Stocks
Forterra to sell U.S. concrete, steel pressure pipe assets to Thompson Pipe »

Forterra announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$8.28

0.48 (6.15%)

, SIRI

SiriusXM

$5.35

0.11 (2.10%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Recommendations
Pandora, SiriusXM analyst commentary  »

Pandora added to Alpha…

P

Pandora

$8.28

0.48 (6.15%)

SIRI

SiriusXM

$5.35

0.11 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TROV

Trovagene

$1.14

-0.16 (-12.31%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Trovagene announces expansion of key claims for NPM1 patent portfolio »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBHC

National Bank

$31.55

-0.18 (-0.57%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Conference/Events
National Bank to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 18

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.